Loading...

BrainsWay Ltd.

BRSYFPNK
Healthcare
Medical - Devices
$6.78
$0.00(0.00%)

BrainsWay Ltd. (BRSYF) Company Profile & Overview

Explore BrainsWay Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

BrainsWay Ltd. (BRSYF) Company Profile & Overview

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

SectorHealthcare
IndustryMedical - Devices
CEOHadar Levy

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, 9777518

Company Facts

120 Employees
IPO DateApr 21, 2011
CountryIL
Actively Trading

Frequently Asked Questions

;